Avaliação do efeito da Dieta Cardioprotetora Brasileira sobre o perfil hiperglicêmico de pacientes com hipertensão e síndrome metabólica

Abstract

Introduction – Metabolic Syndrome (MS) is a complex disorder with a strong genetic basis and a multifactorial etiology. Among the main causes is insulin resistance (IR), which is widely associated with hyperglycemia. To treat this dysfunction, the Brazilian Cardioprotective Diet (BCD), a recent therapeutic proposal, stands out. Aim: to see if the BR-CAD influences hyperglycemia in patients with MS. Goal – Evaluate if diet interventions with the Brazilian Cardioprotective Diet reduces hyperglycemia in patients with metabolic syndrome. Materials and methods – Non-randomized, self-controlled clinical trial. The volunteers were diagnosed with MS, according to the International Diabetes Federation parameters, and followed the DICA-BR for two months. Glycemic profile (fasting glucose, fasting insulin, glycated hemoglobin), MetS cofactors (HDL-cholesterol, triglycerides, waist circumference and blood pressure), anthropometric profile (body weight, body mass index (BMI), fat and lean mass, arm, abdomen and hip circumferences) were assessed. This research was approved by the research ethics committee of the State University of Bahia, number: 6.255.205 and was registered with REBEC:RBR-9v9r6vj. Results – There was no significant difference in the reduction of hyperglycemia (p=0.292); however, there were significant results for glycated hemoglobin (p=0.001) and HOMA-IR (p=0.018); abdomen circumference (p=0.001), hip circumference (p=0.004), body weight (p=0.019) and BC (p=0.008). Conclusions – TIP-BR for two months was not effective in reducing hyperglycemia in volunteers wit